Concurrent Cisplatin-Based Chemoradiation for Cervical Carcinoma: Tumor Response, Toxicity, and Serum Cytokine Profiles

REFERENCES

• Keys H. M., Bundy B. N., Stehman F. B., Muderspach L. I., Chafe W. E., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New Engl. J. Med. 1999; 340: 1154–1161, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rose P. G., Bundy B. N., Watkins E. B., Thigpen J. T., Deppe G., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New Engl. J. Med. 1999; 340: 1144–1153, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Eifel P. J., Winter K., Morris M., Levenback C., Grigsby P. W., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J. Clin. Oncol. 2004; 22: 872–880, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Comerci J. T., Jr., Runowicz C. D., Flanders K. C., De Victoria C., Fields A. L., Kadish A. S., Goldberg G. L. Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. Cancer 1996; 77: 1107–1114, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Braun L., Durst M., Mikumo R., Crowley A., Robinson M. Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor-beta: implications for the control of papillomavirus infection. Mol. Carcinogen. 1992; 6: 100–111, [CSA]
   PubMed Web of Science ®Google Scholar
• Vujaskovic Z., Groen H. J. TGF-beta, radiation-induced pulmonary injury and lung cancer. Int. J. Radiat. Biol. 2000; 76: 511–516, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Li C., Wilson P. B., Levine E., Barber J., Stewart A. L., Kumar S. TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int. J. Cancer 1999; 84: 155–159, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dickson J., Davidson S. E., Hunter R. D., West C. M. Pretreatment plasma TGF beta 1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix. Int. J. Radiat. Oncol. 2000; 48: 991–995, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Jacobsen S. E., Ruscetti F. W., Dubois C. M., Lee J., Boone T. C., Keller J. R. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood 1991; 77: 1706–1716, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gaugler M. H., Squiban C., Mouthon M. A., Gourmelon P., van der M. A. Irradiation enhances the support of haemopoietic cell transmigration, proliferation and differentiation by endothelial cells. Brit. J. Haematol. 2001; 113: 940–950, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chen Y. M., Whang-Peng J., Liu J. M., Wang S. Y., Tsai C. M., Perng R. P. Elevation of serum interleukin-6 levels before peak of serum granulocyte colony-stimulating factor level in chemotherapy-induced myelosuppressive patients. J. Immunother. 1995; 17: 249–254, [CSA]
   Web of Science ®Google Scholar
• Wei L. H., Kuo M. L., Chen C. A., Cheng W. F., Cheng S. P., Hsieh F. J., Hsieh C. Y. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol. Oncol. 2001; 82: 49–56, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Srivani R., Nagarajan B. A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer. Int. J. Gynecol. Cancer 2003; 13: 331–339, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Tang J. T., Yamazaki H., Nishimoto N., Inoue T., Nose T., et al. Effect of radiotherapy on serum level of interleukin 6 in patients with cervical carcinoma. Anticancer Res. 1996; 16: 2005–2008, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 2002; 29: 15–18, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gaffney D. K., Haslam D., Tsodikov A., Hammond E., Seaman J., et al. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Int. J. Radiat. Oncol. 2003; 56: 922–928, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lee I. J., Park K. R., Lee K. K., Song J. S., Lee K. G., et al. Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. Int. J. Radiat. Oncol. 2002; 54: 768–779, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bachtiary B., Selzer E., Knocke T. H., Potter R., Obermair A. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival. Cancer Lett. 2002; 179: 197–203, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Park J. S., Qiao L., Su Z. Z., Hinman D., Willoughby K., et al. Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways. Oncogene 2001; 20: 3266–3280, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Saito S., Kawano Y., Watanabe T., Okamoto Y., Abe T., Kurada Y., Takaue Y. Serum granulocyte colony-stimulating factor kinetics in children receiving intense chemotherapy with or without stem cell support. J. Hematother. 1999; 8: 291–297, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Morstyn G., Campbell L., Souza L. M., Alton N. K., Keech J., et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667–672, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Morstyn G., Campbell L., Lieschke G., Layton J. E., Maher D., et al. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J. Clin. Oncol. 1989; 7: 1554–1562, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jacobsen S. E., Keller J. R., Ruscetti F. W., Kondaiah P., Roberts A. B., Falk L. A. Bidirectional effects of transforming growth factor beta (TGF-beta) on colony-stimulating factor-induced human myelopoiesis in vitro: differential effects of distinct TGF-beta isoforms. Blood 1991; 78: 2239–2247, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar